RPID — Rapid Micro Biosystems Balance Sheet
0.000.00%
- $136.17m
- $105.12m
- $28.05m
- 15
- 23
- 41
- 15
Annual balance sheet for Rapid Micro Biosystems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 45.1 | 193 | 109 | 92.1 | 50.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 5.78 | 5.63 | 5.48 | 5.58 | 7.53 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 62.1 | 218 | 139 | 120 | 80.9 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 7.05 | 11.3 | 20.9 | 19.1 | 16.4 |
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 70 | 241 | 191 | 143 | 98.2 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 15.5 | 18.2 | 19.1 | 19 | 17.6 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 45.2 | 20.2 | 26.5 | 25.5 | 22.8 |
| Redeemable Preferred Stock | |||||
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 24.8 | 221 | 164 | 118 | 75.4 |
| Total Liabilities & Shareholders' Equity | 70 | 241 | 191 | 143 | 98.2 |
| Total Common Shares Outstanding |